Literature DB >> 2797066

Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions.

S Bianco1, M G Pieroni, R M Refini, L Rottoli, P Sestini.   

Abstract

The movement of ions and water across the membranes of bronchial cells is part of the control of the bronchial obstructive response to physical stimuli. In a double-blind, randomized, crossover study, we compared the effect of an aerosol of the loop diuretic furosemide with that of a placebo on the early (within 60 minutes) and late (4 to 12 hours) asthmatic responses to a specific inhaled allergen. We studied 11 subjects with mild allergic asthma, who had both early and late asthmatic responses to a specific inhaled allergen in a preliminary challenge. After placebo administration, the maximal changes (mean +/- SE) from base line in the forced expiratory volume in one second (FEV1) and specific airway resistance were, respectively, a decrease of 35 +/- 4 percent and an increase of 288 +/- 56 percent between 0 and 60 minutes after inhalation of the allergen (early response) and a decrease of 35 +/- 5 percent and an increase of 301 +/- 40 percent between 4 and 12 hours (late response). After furosemide administration (4 ml; 10 mg per milliliter), the early response to inhaled allergen was markedly attenuated in all the subjects, and the late response in all but one. The maximal changes in the FEV1 and specific airway resistance were, respectively, a decrease of 11 +/- 2 percent and an increase of 61 +/- 2 percent between 0 and 60 minutes and a decrease of 20 +/- 4 percent and an increase of 178 +/- 25 percent between 4 and 12 hours (P less than 0.05 for all comparisons). No significant differences were seen in the bronchoconstrictor response to inhaled methacholine after furosemide or placebo administration. We conclude that a furosemide-sensitive mechanism in the airways is involved in the pathogenesis of the reactions of patients with allergic asthma. Whether inhaled furosemide might be useful in the treatment of allergic asthma is uncertain and will require further study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797066     DOI: 10.1056/NEJM198910193211602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

Review 1.  Pharmacotherapy of childhood asthma. An inflammatory disease.

Authors:  H P Van Bever; W J Stevens
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

2.  Inhaled frusemide against cold air induced bronchoconstriction in asthmatic children.

Authors:  J Seidenberg; J Dehning; H von der Hardt
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

3.  Sympathetic nerve-dependent regulation of mucosal vascular tone modifies airway smooth muscle reactivity.

Authors:  Stuart B Mazzone; Lina H K Lim; Elizabeth M Wagner; Nanako Mori; Brendan J Canning
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

4.  Relationship between the acid-induced cough response and airway responsiveness and obstruction in children with asthma.

Authors:  T Shimizu; H Mochizuki; K Tokuyama; A Morikawa
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

5.  Failure of frusemide to increase production of prostaglandin E2 in human nasal mucosa in vivo.

Authors:  J Mullol; I Ramis; J Prat; J Roselló-Catafau; A Xaubet; C Piera; E Gelpí; C Picado
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

6.  The effect of inhaled frusemide on airway sensitivity to inhaled 4.5% sodium chloride aerosol in asthmatic subjects.

Authors:  L T Rodwell; S D Anderson; J I du Toit; J P Seale
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

7.  Inhibition of sodium metabisulphite induced bronchoconstriction by frusemide in asthma: role of cyclooxygenase products.

Authors:  B J O'Connor; P J Barnes; K F Chung
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

8.  Effect of frusemide on the induction and potentiation of cough induced by prostaglandin F2 alpha.

Authors:  P G Ventresca; G M Nichol; P J Barnes; K F Chung
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

9.  Inhibition of inhaled metabisulphite-induced bronchoconstriction by inhaled frusemide and ipratropium bromide.

Authors:  G J Bellingan; C M Dixon; P W Ind
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 10.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.